Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

PHASE3CompletedINTERVENTIONAL
Enrollment

795

Participants

Timeline

Start Date

March 28, 2012

Primary Completion Date

June 21, 2016

Study Completion Date

June 29, 2017

Conditions
Steroid-induced Osteopor, Glucocorticoid-induced Ostepor
Interventions
DRUG

Denosumab

Administered by subcutaneous injection once every 6 months

DRUG

Placebo for risendronate

Administered orally once a day

DRUG

Risendronate

Administered orally once a day

DRUG

Placebo for denosumab

Administered by subcutaneous injection once every 6 months

Trial Locations (99)

1023

Research Site, Budapest

1036

Research Site, Budapest

1114

Research Site, Ciudad Autonoma de Buenos Aires

1200

Research Site, Brussels

2610

Research Site, Wilrijk

2750

Research Site, Ballerup Municipality

3600

Research Site, Genk

3800

Research Site, Szikszó

4000

Research Site, Liège

4032

Research Site, Debrecen

5700

Research Site, Gyula

6720

Research Site, Szeged

7100

Research Site, Vejle

8000

Research Site, Århus C

9000

Research Site, Ghent

Research Site, Aalborg

10117

Research Site, Berlin

16635

Research Site, Duncansville

19610

Research Site, Wyomissing

20817

Research Site, Bethesda

21502

Research Site, Cumberland

25801

Research Site, Beckley

28006

Research Site, Madrid

28046

Research Site, Madrid

30501

Research Site, Gainesville

31134

Research Site, Hildesheim

33029

Research Site, Pembroke Pines

35294

Research Site, Birmingham

37000

Research Site, León

39245

Research Site, Vogelsang-Gommern

44143

Research Site, Mayfield

45067

Research Site, Orléans

46026

Research Site, Valencia

46202

Research Site, Indianapolis

48236

Research Site, Detroit

50937

Research Site, Cologne

54511

Research Site, Vandœuvre-lès-Nancy

58070

Research Site, Morelia

58103

Research Site, Fargo

58104

Research Site, Fargo

60201

Research Site, Evanston

60611

Research Site, Chicago

61231

Research Site, Bad Nauheim

69437

Research Site, Lyon Cédex 3

78200

Research Site, San Luis Potosí City

80227

Research Site, Lakewood

83435

Research Site, Bad Reichenhall

95817

Research Site, Sacramento

105077

Research Site, Moscow

115522

Research Site, Moscow

150003

Research Site, Yaroslavl

190068

Research Site, Saint Petersburg

190103

Research Site, Saint Petersburg

194291

Research Site, Saint Petersburg

603155

Research Site, Nizhny Novgorod

620102

Research Site, Yekaterinburg

02118

Research Site, Boston

C1128AAF

Research Site, Ciudad Autonoma de Buenos Aires

C1431FBO

Research Site, Buenos Aires

V5Z 4E1

Research Site, Vancouver

L4M 6L2

Research Site, Barrie

L8N 1Y2

Research Site, Hamilton

N2J 1C4

Research Site, Waterloo

H2L 1S6

Research Site, Montreal

H3Z 2Z3

Research Site, Montreal

G1V 3M7

Research Site, Québec

G8Z 1Y2

Research Site, Trois-Rivières

H3Z 1E5

Research Site, Westmout

S7K 0H6

Research Site, Saskatoon

08001000

Research Site, Barranquilla

602 00

Research Site, Brno

530 02

Research Site, Pardubice

305 99

Research Site, Pilsen

128 50

Research Site, Prague

130 00

Research Site, Prague

148 00

Research Site, Praha 11 - Chodov

686 01

Research Site, Uherské Hradiště

06100

Research Site, Mexico City

1081 HV

Research Site, Amsterdam

5707 HA

Research Site, Helmond

3584 XC

Research Site, Utrecht

15-879

Research Site, Bialystok

31-501

Research Site, Krakow

90-368

Research Site, Lodz

60-218

Research Site, Poznan

60-356

Research Site, Poznan

37-450

Research Site, Stalowa Wola

87-100

Research Site, Torun

01-192

Research Site, Warsaw

04-730

Research Site, Warsaw

51-124

Research Site, Wroclaw

700-712

Research Site, Daegu

301-721

Research Site, Daejeon

501-757

Research Site, Gwangju

660-702

Research Site, Jinju

120-752

Research Site, Seoul

137-701

Research Site, Seoul

150-713

Research Site, Seoul

08041

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01575873 - Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids | Biotech Hunter | Biotech Hunter